ARCHIVES

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

NIH Expands Minority Biomedical Research Training

July 11, 1975

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982